Fibrocell Science, Inc. Accounts Receivable
Fibrocell Science, Inc. had Accounts Receivable of $2.52 million as of 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2019-11-14
- 2019-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $2.52M.
- 2019-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $1.91M.
- 2019-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $294.00K.
- 2018-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $0.00.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2019-09-30 | $2.52M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $1.91M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $294.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-14 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 |
| 2015-12-31 | $0.00 10-Q · filed 2016-05-05 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-05 |
| 2015-06-30 | $3.00K 10-Q · filed 2015-08-07 |
| 2015-03-31 | $3.00K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $4.00K 10-K · filed 2016-03-10 |
| 2014-09-30 | $2.00K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $14.00K 10-Q · filed 2014-08-11 |
| 2014-03-31 | $58.00K 10-Q · filed 2014-05-19 |
| 2013-12-31 | $28.00K 10-K · filed 2015-03-13 |
| 2013-09-30 | $45.00K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $72.00K 10-Q · filed 2013-08-13 |
| 2013-03-31 | $26.00K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $62.00K 10-K/A · filed 2014-06-02 |
| 2011-12-31 | $27.00K 10-K/A · filed 2014-06-02 |